期刊文献+

肌酸激酶同工酶POCT检测系统的性能评价 被引量:5

The creatine kinase isoenzyme POCT method detection system performance evaluation
下载PDF
导出
摘要 目的评价Triage Metet荧光免疫干式快速定量检测系统检测肌酸激酶同工酶(CK-MB)的精密度、正确度,以确保床边检验(POCT)结果的可靠性。方法采用美国临床与实验室标准化协会(CLSI)EP5-A2文件进行精密度验证,采用EP9-A2文件对Triage Metet荧光免疫干式快速定量分析仪与mini VIDAS全自动荧光免疫分析仪进行方法学比对,验证正确度。结果 CK-MB均值为5.00、39.10ng/mL时CV批内分别为3.40%、0.79%,CV总分别为3.40%、1.07%,均小于厂家声明的不精密度;CK-MB在两仪器的比对结果相关性良好(r2=0.998 6,P<0.05),CK-MB的医学决定水平分别为15、90,相对偏差(SE%)分别为2.53%、0.17%,均小于1/4CLIA′88的允许误差(30%)。结论美国Biosite Biagnostics公司生产的Triage Metet荧光免疫干式快速定量检测系统测定CK-MB的精密度、正确度性能良好,可满足临床需求。 Objective To Evaluate the precision and accuracy of triage metet fluorescence immunoassay dry quick quantitative detection system in the detection of creatine kinase isoenzyme(CK-MB) to ensure the reliability of bedside testing(POCT) results.Methods The American clinical and Laboratory Standards Institute(CLSI) EP5-A2 file was applied in precision verification,the EP9-A2 file was applied in the method comparison between Triage Metet fluorescence immunoassay dry fast quantitative analyzer and mini VIDAS automated fluorescence immunoassay analyzer,and verify the correctness.Results When the mean CK-MB was 5,39.10 ng/mL,the CV with a group were 3.40,0.79 respectively,CV among groups 3.40,1.07 respectively,which were less than manufacturers′ declaration of imprecision;CK-MB results in two instrument were correlated well(r2=0.998 6,P&lt;0.05),When the medical decision level of CK-MB were 15 and 90,relative standard deviation SE% were 2.53% and 0.17% respectively,which are less than 1/4 allowable error of CLIA′88(30%).Conclusion The triage metet fluorescence immunoassay dry quick quantitative detection system produced by United States Biosite Biagnostics are with good precision and accuracy in the detection of CK-MB,which meets the clinical needs.
出处 《国际检验医学杂志》 CAS 2013年第10期1209-1211,共3页 International Journal of Laboratory Medicine
关键词 床边检验 肌酸激酶同工酶 酶联荧光 性能评价 point of care testing creatine kinase isoenzyme enzyme-linked fluorescent performance evaluation
  • 相关文献

参考文献8

二级参考文献48

  • 1胡勤辛,叶雄伟,毕其华.20台POCT血糖仪对照试验及现状调查分析[J].实用糖尿病杂志,2005,13(1):21-23. 被引量:22
  • 2Thom T, Haase N, Rosamond W, et al. Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Sub committee [J]. Circulation, 2006, 113(6): e85-e151.
  • 3Yang Z, Min-Zhou D. Cardiac markers and their point-of-care testing for diagnosis of acute myocardial infarction [J]. Clin Bio chem, 2006, 39(8): 771-780.
  • 4Azzazy HM, Christenson RH. Cardiac markers of acute coronary syndromes: is there a case for point-of-care testing [J]. Clin Biochem, 2002, 35(1): 13-27.
  • 5Panteghini M. Role and importance of biochemical markers in clinical cardiology[J]. Eur Heart J,2004,25(14) :1 187-1 196.
  • 6Melanson SF, Tanasijevic MJ. Laboratory diagnosis of acute myocardial injury [J]. Cardiovasc Pathol, 2005, 14(3) : 156-161.
  • 7Babuin L, Jaffe AS. Troponin: the biomarker of choice for the detection of cardiac injury [J]. CMAJ, 2005, 173 (10) : 1 191- 1 202.
  • 8Wu AH. Markers for early detection of cardiac diseases [J]. Scand J Clin Lab Invest Suppl, 2005, 240: 112-121.
  • 9Apple FS, Wu AH, Mair J, et al. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome [J]. Clin Chem, 2005, 51(5): 810-824.
  • 10Hunt SA, Baker DW, Chin MH, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Eval uation and Management of Heart Failure) [J]. J Am Coll Cardiol, 2001, 38(7):2 101-2 113.

共引文献105

同被引文献34

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部